2. Hepatitis C Virus Can Evolve Resistance To microRNA-122 Inhibitors
Gavriel Mullokandov(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Marion Sourisseau(Icahn School of Medicine at Mount Sinai), Andres Y. Maldonado(Icahn School of Medicine at Mount Sinai), Judith Agudo(Dana-Farber Cancer Institute), Matthew J. Evans(Icahn School of Medicine at Mount Sinai), Benjamin Israelow(Yale University), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Ali Bashir(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
Diverse functional autoantibodies in patients with COVID-19
|Nature|2021|984